BOLD
Boundless Bio, Inc. Common Stock
NASDAQ: BOLD · HEALTHCARE · BIOTECHNOLOGY
$1.46
+0.69% today
Updated 2026-04-30
Market cap
$33.61M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.60
Dividend yield
—
52W range
$1 – $2
Volume
0.2M
Boundless Bio, Inc. Common Stock (BOLD) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2016 | 2017 | 2018 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $142.06M | $178.66M | $472.56M | $113.72M | $76.83M | $129.89M | $206.41M | $157.06M |
| Cash & equivalents | $36.36M | $38.97M | $144.35M | $34.29M | $10.95M | $23.71M | $26.59M | $17.87M |
| Current assets | $108.44M | $137.01M | $419.77M | $74.57M | $68.04M | $124.20M | $154.39M | $109.61M |
| Total liabilities | $22.69M | $22.06M | $29.80M | $151.91M | $158.53M | $256.98M | $55.77M | $58.41M |
| Current liabilities | $12.56M | $17.71M | $23.85M | $3.87M | $7.73M | $9.36M | $8.13M | $12.54M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Shareholder equity | $119.37M | $156.60M | $442.75M | $-38.19M | $-81.70M | $-127.08M | $150.64M | $98.65M |
| Retained earnings | $-100.41M | $-190.65M | $-319.47M | $-40.77M | $-86.67M | $-136.11M | $-201.47M | $-259.67M |
| Accounts receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Goodwill | $3.63M | $3.63M | $3.63M | — | — | — | — | — |